After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in Government of Canada funding was awarded through Genome Canada, to create a coordinated, large-scale, diverse genomic data asset of 100,000 genomes that reflects Canada’s population.
With this investment, SickKids will sequence the genomes of 10,000 children and drive forward innovations that tailor treatments to a child’s individual genetics, providing more effective and personalized care – an initiative that aligns closely with the Ted Rogers Centre for Heart Research’s mission to transform cardiac care through precision medicine, data-driven approaches, and innovative research.
For children with heart disease, precision medicine holds transformative potential. This funding will allow SickKids researchers, through the TRCHR Cardiac Precision Medicine Program (Scientific lead, Seema Mital), to improve their understanding of the genetic causes of pediatric cardiac conditions, accelerating the discovery of novel biomarkers and therapeutic targets. By combining these insights with cardiovascular genomics and digital health, we are poised to create more predictive, preventative, and personalized interventions.
This funding from Genome Canada accentuates the potential behind precision child health and the power of collaborative research. As we look ahead, this investment marks another step toward a shared goal, ensuring that everyone receives the right treatment, at the right time, based on their unique biology. With advancements in genomics and precision medicine, the future of heart health is brighter than ever.
